Insider buying last 90 days
No open-market insider purchases were filed for MMS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Maximus this week centers on its Q3 fiscal 2026 results and outlook. Revenue of $1.28 billion met expectations, with adjusted EPS of $2.22 slightly above the prior year, and the company maintained full-year revenue guidance while revising EPS guidance due to a temporary pause in performance incentives on a major VA contract. Separately, the company declared a quarterly cash dividend of $0.33 per share, payable 30 November to shareholders of record as of 13 November, and scheduled its fiscal fourth-quarter and year-end call.
Shares closed at $58.87, down 0.9%, sitting between the 50-day average of $56.82 and the 200-day average of $66.87, a mixed trend picture. The GekkoIndex reads 51.6, placing the stock in the Neutral zone, down from a five-day change of -11.6. Price sits 43.2% below Gekko Fair Value of $103.56, a notable gap.
The next earnings date falls on 19 November 2026, before the open, which is 38 days away and outside a typical 20-trading-day holding window. The prior report on 6 August showed an EPS beat with a -6.3% reaction, and average absolute reactions have run 8.9% across recent quarters. No insider, Congress or unusual options activity appears in the recent windows. Seasonally, the next 20 trading days have averaged +0.4% over five years, rising in 2 of them, a mixed historical pattern worth noting.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Maximus scores 2 supportive, 3 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive3 mixed0 headwinds
Averages disagree
Close $58.87 sits between the 50-day ($56.82) and 200-day ($66.87) averages, or the averages disagree.
See the chart51.6, Neutral
Reading 51.6 is in the Neutral zone.
See the GekkoIndex43.2% below
Price is 43.2% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 38 days
Next report Nov 19, 2026, 38 days away — outside a typical 20-trading-day hold.
See earnings+0.4% on average
From this point in the calendar, the next 20 trading days averaged +0.4% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Maximus closed at $58.87 on Oct 12, 2026, −33.3% over the past year, inside a 52-week range of $51.04 to $100.00.
Use the left and right arrow keys to read daily values.
Put MMS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Maximus provides business process services that help governments run health and human welfare programs. It is best known for operating the administrative and support work behind initiatives such as Medicaid, the Children's Health Insurance Program, the Affordable Care Act, and related benefit and assessment programs, acting as the operational layer between public agencies and the people those programs serve.
The company organizes its work into three segments. U.S. Services supports state and local government programs through eligibility and enrollment processing, multilingual contact centers, independent assessments, appeals handling, and consulting. U.S. Federal Services works with federal agencies, managing citizen engagement centers, case management, medical and benefit appeals, IT modernization, and data analytics. Its international segment, described as operations outside the U.S., serves both government and commercial clients with health and disability evaluations and employment program administration aimed at job seekers.
Maximus was established in 1975 and is headquartered in Tysons, Virginia. Its shares are listed on the NYSE under the ticker MMS.
Maximus’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 51.6, in the Neutral zone, down 11.6 points over five sessions.
Down 11.6 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 70 | −0.4% | +2.4% | ||
| Accumulation | 229 | +1.0% | −0.5% | ||
| Neutral (current zone) | 340 | −1.0% | −1.4% | ||
| Distribution | 42 | +0.3% | −3.1% | ||
| Selling | 1 | Too few readings yet | |||
Average MMS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Maximus trades 43.2% below Gekko Fair Value of $103.56, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Maximus shares are worth, recalculated every trading day.
$103.56
Gekko Fair Value, Oct 10, 2026
43.2% Undervalued
At the end of Aug 2026 the price was 28.1% below the estimate.
No open-market insider purchases were filed for Maximus, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MMS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MMS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Maximus has been buying back its own shares.
From company filings.
Maximus reports on Nov 19, 2026, before the open (38 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 19, 2026
Expected before the open, 38 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $2.22 est $2.21 | $1.28B est $1.33B | −6.3% |
| May 7, 2026 | $2.07 est $1.97 | $1.31B est $1.32B | +0.5% |
| Feb 5, 2026 | $1.85 est $1.84 | $1.35B est $1.37B | −19.9% |
| Nov 20, 2025 | $1.62 est $1.67 | $1.32B est $1.34B | +9.1% |
| Aug 7, 2025 | $2.16 est $1.39 | $1.35B est $1.34B | +8.8% |
| May 8, 2025 | $2.01 est $1.37 | $1.36B est $1.29B | +12.2% |
| Feb 6, 2025 | $1.61 est $1.39 | $1.40B est $1.29B | −8.0% |
| Nov 20, 2024 | $1.46 est $1.49 | $1.32B est $1.31B | −6.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Maximus is $92.50, +57.1% from the last close.
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Maximus averaged +0.4% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 4 of 5 |
| Next 10 trading days | −1.2% | 2 of 5 |
| Next 15 trading days | +0.4% | 2 of 5 |
| Next 20 trading days | +0.4% | 2 of 5 |
| Next 30 trading days | −0.3% | 2 of 5 |
For scale, MMS’s typical 20-trading-day move in either direction is about 4.1%.
Maximus’s market cap is $3.09B, with a P/E ratio of 8.7 and revenue of $5.25B over the last twelve months.
Coverage of Maximus this week reads positive: 7 positive, 5 neutral and 0 negative headlines.
Maximus’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| SHOPShopify | Distribution | 25.9% above |
| CTASCintas | Neutral | 14.1% above |
| PYPLPayPal | Neutral | 0.8% below |
| XYZBlock | Neutral | 7.5% above |
| CPAYCorpay | Neutral | 17.5% below |
| FISVFiserv | Accumulation | 39.7% below |
A peer links to its own page where one exists.
Maximus’s market cap is $3.09B at the Oct 12, 2026 close of $58.87, with 52.36M shares outstanding. The shares trade on a P/E ratio of 8.7.
The consensus analyst 12-month price target for Maximus is $92.50, +57.1% from the last close. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Maximus is undervalued: the Oct 12, 2026 close of $58.87 is 43.2% below Gekko Fair Value of $103.56. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Maximus is expected to report on Nov 19, 2026, before the market opens (38 days away). Analysts expect earnings of $1.88 per share on revenue of $1.30B. Maximus beat the earnings estimate in 6 of its last 8 reports, moving 8.9% on average across the report.
Maximus’s 52-week high is $100.00 and its 52-week low is $51.04; it closed at $58.87 on Oct 12, 2026, −33.3% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (fair value and earnings risk), 3 as mixed (trend, gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.